NCT01757119

Ferrous Sulphate Supplement in Women With Iron Deficiency Anaemia

Study of the Pharmacokinetics of Serum Iron After Single Oral Administration of Ferrous Sulphate Supplement in Women With Iron Deficiency Anaemia

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 55 (actual)
• Sponsor: Pierre Fabre Medicament · Industry
• Sex: Female
• Age: 18 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to investigate the pharmacokinetics of serum iron (the amount of iron in blood) after single oral administration of 2 tablets of L0008 80 mg (as ferrous sulphate) in women with iron deficiency anaemia.

Conditions

• Iron Deficiency Anemia

Interventions

Type	Name	Description
DRUG	Tardyferon 80 mg	Oral administration (2 tablets)

Timeline

• Start date: 2013-01-01
• Primary completion: 2014-03-01
• Completion: 2014-03-01
• First posted: 2012-12-28
• Last updated: 2014-04-15

Locations

2 sites across 1 country: Romania